BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$2.11B |
| 2 |
Veralto
VLTO
|
+$1.29B |
| 3 |
Blackstone
BX
|
+$1.1B |
| 4 |
Extra Space Storage
EXR
|
+$964M |
| 5 |
Airbnb
ABNB
|
+$935M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$2.47B |
| 2 |
Apple
AAPL
|
+$1.51B |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$1.29B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$1.09B |
| 5 |
NVIDIA
NVDA
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Healthcare | 13.55% |
| 3 | Financials | 11.73% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
4D Molecular Therapeutics
FDMT
$545M
| $39.8M | ﹤0.01% |
3,123,676
+209,246
| +7% | +$3.5M |
|
2527
Anavex Life Sciences
AVXL
$295M
| $39.7M | ﹤0.01% |
6,061,191
+122,223
| +2% | +$973K |
|
|
EWCZ
2528
DELISTED
European Wax Center
EWCZ
| $39.7M | ﹤0.01% |
2,448,145
+84,607
| +4% | +$1.52M |
|
2529
Beyond Meat
BYND
$315M
| $39.5M | ﹤0.01% |
4,110,635
-44,883
| -1% | -$585K |
|
2530
Montauk Renewables
MNTK
$242M
| $39.5M | ﹤0.01% |
4,334,789
-41,447
| -0.9% | -$372K |
|
2531
Dream Finders Homes
DFH
$1.33B
| $39.5M | ﹤0.01% |
1,776,338
+246,285
| +16% | +$6.4M |
|
2532
Playtika
PLTK
$1.53B
| $39.5M | ﹤0.01% |
4,099,212
+1,524,273
| +59% | +$16.3M |
|
2533
Immunocore
IMCR
$1.67B
| $39.4M | ﹤0.01% |
759,833
-32,251
| -4% | -$1.91M |
|
2534
Theravance Biopharma
TBPH
$875M
| $39.4M | ﹤0.01% |
4,566,930
-514,285
| -10% | -$4.97M |
|
2535
CGI
GIB
$15.2B
| $39.4M | ﹤0.01% |
399,807
+1,944
| +0.5% | +$199K |
|
2536
PubMatic
PUBM
$631M
| $39.4M | ﹤0.01% |
3,253,223
-57,994
| -2% | -$882K |
|
2537
Tarsus Pharmaceuticals
TARS
$2.64B
| $39.3M | ﹤0.01% |
2,210,323
+10,570
| +0.5% | +$187K |
|
2538
Vanguard Morningstar Small-Cap ETF
VB
$82B
| $39.2M | ﹤0.01% |
207,275
-233
| -0.1% | -$46.4K |
|
2539
Ceco Environmental
CECO
$4.09B
| $39.2M | ﹤0.01% |
2,453,266
-164,341
| -6% | -$2.25M |
|
2540
Woori Financial
WF
$17.1B
| $39.1M | ﹤0.01% |
1,425,504
-56,050
| -4% | -$1.51M |
|
|
EBIX
2541
DELISTED
Ebix Inc
EBIX
| $39M | ﹤0.01% |
3,951,266
-38,432
| -1% | -$747K |
|
2542
CALL
Tesla
TSLA
$1.28T
| $39M | ﹤0.01% |
156,000
-255,700
| -62% | -$65.7M |
|
2543
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$41.8B
| $39M | ﹤0.01% |
+440,000
| New | +$42.3M |
|
2544
National Grid
NGG
$80.6B
| $38.8M | ﹤0.01% |
678,345
+25,091
| +4% | +$1.52M |
|
|
CNSL
2545
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $38.7M | ﹤0.01% |
11,328,549
-651,736
| -5% | -$2.4M |
|
|
CBL
2546
CBL Properties
CBL
$1.77B
| $38.7M | ﹤0.01% |
1,846,474
-7,878
| -0.4% | -$171K |
|
|
HDSN
2547
Hudson Technologies
HDSN
$261M
| $38.7M | ﹤0.01% |
2,911,113
+9,237
| +0.3% | +$99.7K |
|
2548
Zumiez
ZUMZ
$335M
| $38.6M | ﹤0.01% |
2,167,569
+563,502
| +35% | +$10.2M |
|
|
RAPT
2549
DELISTED
RAPT Therapeutics
RAPT
| $38.5M | ﹤0.01% |
289,852
+18,046
| +7% | +$2.95M |
|
2550
GoPro
GPRO
$126M
| $38.4M | ﹤0.01% |
12,235,040
+495,572
| +4% | +$1.88M |
|
Similar funds
BlackRock's Q3 2023 Portfolio in Review
As of Q3 2023, BlackRock held 5,656 positions worth $3.48T, down 4.1% from $3.63T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BlackRock's Q3 2023 filing shows 156 new, 2,077 increased, 2,595 reduced and 210 closed positions. Its largest new stake was Veralto: 15,466,356 shares worth $1.31B. The largest sale was Johnson & Johnson, an estimated $2.47B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2023 buy was Veralto: 15,466,356 shares worth $1.31B.
- BlackRock added most to Kenvue in Q3 2023, an estimated $2.11B increase.
- BlackRock's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $2.47B.
- BlackRock fully exited Life Storage, Inc. in Q3 2023, selling an estimated $1.29B.
- BlackRock's ten largest holdings make up 22% of its $3.48T portfolio in Q3 2023.
- BlackRock opened 156 new positions and closed 210 in Q3 2023.
- BlackRock's portfolio value fell 4.1% quarter-over-quarter to $3.48T.
Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.